Oscar Health, Inc. (OSCR)
NYSE: OSCR · Real-Time Price · USD
29.79
+1.12 (3.91%)
At close: Jun 26, 2026, 4:00 PM EDT
29.70
-0.09 (-0.32%)
After-hours: Jun 26, 2026, 7:59 PM EDT

Oscar Health Stock Forecast

Stock Price Forecast

According to 11 analysts polled by S&P Global, Oscar Health stock has a consensus rating of "Hold" and an average price target of $22.6. The average 1-year stock price forecast is 24.14% lower than the current stock price, while the lowest is $13 (-56.36%) and the highest is $35 (+17.49%).

Price Target: $22.6 (-24.14%)
Analyst Consensus: Hold
TargetLowAverageMedianHigh
Price$13$22.6$21$35
Change-56.36%-24.14%-29.51%+17.49%

Analyst Ratings

The average analyst rating for Oscar Health stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy000000
Buy122223
Hold655677
Sell111111
Strong Sell222110
Total101010101111

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Barclays
Barclays
Buy
Upgrades
$30$35
BuyUpgrades$30$35+17.49%Jun 11, 2026
Wells Fargo
Wells Fargo
Hold
Upgrades
$11$20
HoldUpgrades$11$20-32.86%Jun 4, 2026
Scott Fidel
Goldman Sachs
Goldman Sachs
Hold
Reiterates
$17$22
HoldReiterates$17$22-26.15%May 11, 2026
Robert W. Baird
Robert W. Baird
Hold
Maintains
$15$19
HoldMaintains$15$19-36.22%May 7, 2026
Bank of America Securities
Bank of America Securities
Sell
Maintains
$11$13
SellMaintains$11$13-56.36%May 7, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
18.55B
from 11.70B
Increased by 58.50%
Revenue Next Year
19.79B
from 18.55B
Increased by 6.70%
EPS This Year
1.06
from -1.69
EPS Next Year
1.48
from 1.06
Increased by 40.28%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
1.89B3.96B5.86B9.18B11.70B18.55B
Revenue Growth
384.43%109.27%47.92%56.54%27.50%58.50%
Net Income
-572.61M-606.28M-270.73M25.43M-443.15M383.51M
EPS
-----1.691.06
Forward PE
---28.43-28.15
Free Cash Flow
-253.85M-230.88M538.86M1.04B698.00M3.38B
No. Analysts
-----9
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High18.9B
Avg18.5B
Low17.2B

Revenue Growth

Revenue Growth202620272028
High
61.8%
Avg
58.5%
Low
46.6%

EPS Forecast

EPS202620272028
High1.38
Avg1.06
Low0.63

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-